StockNews.AI
MYGN
StockNews.AI
55 days

INVESTOR ALERT: Investigation of Myriad Genetics, Inc. (MYGN) Announced by Holzer & Holzer, LLC

1. Holzer & Holzer investigates Myriad Genetics for securities law compliance issues. 2. Myriad lowered 2025 financial guidance due to 20% revenue decline. 3. The stock price dropped following the announcement of the financial results. 4. Legal representation offered to investors who lost money on Myriad stock.

3m saved
Insight
Article

FAQ

Why Bearish?

The recent revenue decline and lowered guidance indicate financial instability, which historically leads to stock price drops. Similar cases have seen shares fall 10-30% following such announcements.

How important is it?

The ongoing investigation and revenue decline directly affect investor confidence and stock price.

Why Short Term?

Immediate investor sentiment is likely driven by the latest report. Over time, performance improvements could mitigate impacts.

Related Companies

ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Myriad Genetics, Inc. (“Myriad Genetics” or the “Company”) (NASDAQ: MYGN) complied with federal securities laws. On May 6, 2025, Myriad Genetics reported first quarter 2025 financial results, and lowered its 2025 financial guidance, revealing, among other things, a decline in pharmacogenomics revenue by 20% year-over-year “due to UnitedHealthcare (UNH) reduc[ing] coverage of GeneSight.” Following this news, the price of the Company’s stock dropped.  If you purchased Myriad Genetics stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/myriad-genetics/ to discuss your legal rights. Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. CONTACT:  Corey Holzer, Esq.(888) 508-6832 (toll-free) cholzer@holzerlaw.com

Related News